EV
Elsas Andrea van
Chief Scientific Officer

Elsas Andrea van insider trades: Aduro Biotech (ADRO) stock sales

Chief Scientific Officer, Aduro Biotech Last trade Feb 25, 2020 19 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2017
1
Company
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Elsas reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 25, 2020ADRO↓ Sell$24K
Jan 3, 2020ADRO↓ Sell$87K
Dec 12, 2019ADRO↓ Sell$3K
Sep 13, 2019ADRO↓ Sell$24K
Mar 19, 2019ADRO↓ Sell$24K
Feb 26, 2019ADRO↓ Sell$29K
Dec 28, 2018ADRO↓ Sell$5K
Dec 12, 2018ADRO↓ Sell$6K
Sep 24, 2018ADRO↓ Sell$45K
Sep 13, 2018ADRO↓ Sell$63K
Jul 17, 2018ADRO↓ Sell$73K
Feb 26, 2018ADRO↓ Sell$45K
Sep 13, 2017ADRO↓ Sell$54K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Elsas Andrea van's insider trades

Elsas Andrea van is Chief Scientific Officer at Aduro Biotech (ADRO). Since Sep 13, 2017, Elsas has reported no open-market purchases and 13 sales worth $482K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADRO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.